Lucía Gandullo-Sánchez

4PUBLICATIONS
21CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 12, 2022
Therapy-Induced Senescence Enhances the Efficacy of HER2-Targeted Antibody-Drug Conjugates in Breast Cancer.

Santiago Duro-Sánchez, Mercedes Nadal-Serrano, Marta Lalinde-Gutiérrez

|May 28, 2022
Antitumoral Activity of a CDK9 PROTAC Compound in HER2-Positive Breast Cancer.

María Del Mar Noblejas-López, Lucía Gandullo-Sánchez, Eva M Galán-Moya

|Jan 11, 2022
Novel ADCs and Strategies to Overcome Resistance to Anti-HER2 ADCs.

Elena Díaz-Rodríguez, Lucía Gandullo-Sánchez, Alberto Ocaña

|Sep 28, 2021
Generation of Antibody-Drug Conjugate Resistant Models.

Lucía Gandullo-Sánchez, Alberto Ocaña, Atanasio Pandiella

Pageof 1